Eye Prosthesis (e.g., Lens Or Corneal Implant, Or Artificial Eye, Etc.) Patents (Class 623/4.1)
  • Patent number: 11058580
    Abstract: An orbital tissue retractor 10 for use in a surgical operation in the region of an eye socket, comprises an orbital tissue retractor body 12 and a handle 14 extending therefrom for manipulation of the tissue retractor body by a surgeon. The tissue retractor body comprises a channel formation 16 defining a channel 17. The channel formation 16 has a pair of spaced side wall sections 24 which define concave curved ocular abutment formations 26 which conform to an anatomical curvature of the ocular globe for abutment with the ocular globe N. The tissue retractor body has open proximal end 22 and an open distal end 20. The tissue retractor body tapers from the proximal end to the distal end, with a portion of the channel formation at the distal end being curved so as to accommodate and cradle the optic nerve therein. The retractor body has a curved base wall section 28 conforming to an anatomical curvature of the orbit.
    Type: Grant
    Filed: November 2, 2017
    Date of Patent: July 13, 2021
    Assignee: Liqid Medical Proprietary Limited
    Inventor: Daemon Bruce McClunan
  • Patent number: 11058533
    Abstract: A device for implantation into an eye for supporting an intraocular lens during and following surgery. The device may include a ring and at least one support. The ring may have an open portion defined between a first eyelet on a first end and a second eyelet on a second end, the ring being radially compressible. The at least one support may be defined internally of the ring and have a position on which a lens is nestably engaged with the at least one support above a tear in the capsular bag of the eye.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: July 13, 2021
    Inventor: Rajesh Dalvi
  • Patent number: 11052055
    Abstract: A modular transdermal drug delivery system is provided, the system including: an upper module in which an outer backing layer is laminated to a pressure-sensitive adhesive layer that is covered by a removable release liner prior to assembly; and a lower module with a porous drug reservoir layer laminated to a skin-contact adhesive that affixes the system to the skin during drug delivery, where the skin-contact adhesive is, in one embodiment, an adhesive layer that is substantially co-extensive with the porous drug reservoir layer and, prior to use, protected with a second removable release liner. Methods of manufacture and use are also provided, as is an assembled transdermal drug delivery system fabricated by affixing the pressure-sensitive adhesive layer of the upper module to the porous drug reservoir layer of the lower module.
    Type: Grant
    Filed: October 2, 2019
    Date of Patent: July 6, 2021
    Assignee: PURE RATIOS HOLDING, INC
    Inventor: Frank Kochinke
  • Patent number: 11000188
    Abstract: A smart body analyzer apparatus includes a rotatable plate for supporting and turning a body, a control unit for rotating the rotatable plate, and at least one group of touch-less sensors for scanning the body. Examples of touch-less sensors include a far infrared temperature sensor and a depth sensor. The depth sensor can employ a time-of-flight imaging method, a stereoscopic imaging method, a microwave imaging method and/or a laser ranging method based on trigonometric principles.
    Type: Grant
    Filed: July 13, 2017
    Date of Patent: May 11, 2021
    Assignee: NAKED LAB AUSTRIA GMBH
    Inventors: Farhad Farahbakhshian, Peter Kreuzgruber
  • Patent number: 10860823
    Abstract: A scanning system is providing including a scanner and a scan crutch. The scanner includes a housing, a window in an upper end of the housing, and a light emitter/receiver in the housing under the window. The scan crutch is attached to the scanner and includes a base and a protrusion extending from the base in a direction away from the scanner. The protrusion of the scan crutch ensures accurate and repeatable scanning of target objects by allowing a user to quickly position the scanner at an optimum distance from a target object by contacting the target object with the protrusion of the scan crutch.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: December 8, 2020
    Assignee: PADRES L.P.
    Inventor: Gabriel Kunde
  • Patent number: 10828473
    Abstract: Systems and methods for treating ocular disorders are disclosed. One system has a delivery instrument, with a non-linear axis, configured to be inserted into an anterior chamber of an eye and moved to a location proximate a physiologic outflow pathway of the eye. The delivery instrument carries an implant that has a distal end sized for insertion into tissue such that aqueous humor drains from the anterior chamber to the physiologic outflow pathway. One method involves inserting a non-linear portion of a delivery device into the anterior chamber to position an implant within the eye. Another method involves using a delivery device with a curved distal portion to implant an implant at a location communicating with the physiologic outflow pathway. The delivery can be through a corneal incision and the implant can comprise a drug.
    Type: Grant
    Filed: May 29, 2018
    Date of Patent: November 10, 2020
    Assignee: Glaukos Corporation
    Inventors: David Steven Haffner, Gregory T. Smedley, Hosheng Tu, Barbara A. Niksch, Richard A. Hill, Olav B. Bergheim
  • Patent number: 10799340
    Abstract: An IOL system includes a capsular ring having a concave exterior surface extending around its circumference that is configured, upon insertion into a capsular bag of a patient's eye, to engage an equatorial region of the capsular bag. The concave exterior surface extends between an anterior surface and a posterior surface of the capsular ring. A first one or more flaps are arranged on the anterior surface such that at least a portion of each of the first one or more flaps, upon insertion into the capsular bag of a patient's eye, engages an anterior portion of the capsular bag. Similarly, a second one or more flaps are arranged on the posterior surface such that at least a portion of each of the second one or more flaps, upon insertion into a capsular bag of a patient's eye, engages a posterior portion of the capsular bag.
    Type: Grant
    Filed: August 10, 2015
    Date of Patent: October 13, 2020
    Assignee: Alcon Inc.
    Inventors: Stephen Collins, Niranjana Nandakumar, John Radle, Stephen Van Noy, Douglas B. Wensrich
  • Patent number: 10786347
    Abstract: A scleral belt with an elongate strap having a first end and a second end. The strap has a plurality of openings disposed near the first end. A loop is disposed near the second end of the strap. A frame may be pivotally attached at the second end. The frame supports a prong which is pivotally attached to the frame. The first end of the strap passes through the frame and the loop, and the prong engages with one of the openings to fix the position of the two ends of the strap. The operation of the improved scleral belt makes it easier to adjust the scleral belt to adjust the height and location of the “buckling effect.
    Type: Grant
    Filed: November 12, 2018
    Date of Patent: September 29, 2020
    Inventor: Mehdi Ali Khan
  • Patent number: 10736735
    Abstract: The present invention relates generally to the fields of ophthalmology and cataract surgery. More specifically, the present invention relates to a device implanted in the eye during cataract surgery and improves the optical functionality of the eye. This invention is in the field of medical devices and relates to capsular tension rings that are designed to be implanted in the capsular sac after removal of the crystalline lens affected by a cataract in association with an intraocular lens designed to replace the crystalline lens. The invention applies to stabilizing the artificial lens from movement in the x-y-z planes and prevents rotation.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: August 11, 2020
    Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventor: Malik Y. Kahook
  • Patent number: 10555837
    Abstract: Intraocular apparatus is provided, having an anterior side and a posterior side, and configured for use with an extraocular imaging device. The intraocular apparatus includes a photovoltaic energy receiver, or an RF energy receiver, on the anterior side which receives energy from outside the eye to power the intraocular apparatus. Additionally, the intraocular apparatus includes a photodiode on the anterior side of the intraocular apparatus which receives data from the extraocular imaging device. An application-specific-integrated-circuit (ASIC) is positioned on the posterior side of the intraocular apparatus and includes (i) circuitry configured to process the data from the photodiode into an image, (ii) an electronic display, e.g., a light-emitting diode (LED) display, which emits light representing the image, and (iii) at least two through-silicon vias connecting the ASIC to the photovoltaic energy receiver and to the photodiode. Other applications are also described.
    Type: Grant
    Filed: September 12, 2016
    Date of Patent: February 11, 2020
    Assignee: RAINBOW MEDICAL LTD.
    Inventors: Tuvia Liran, Yossi Gross
  • Patent number: 10467992
    Abstract: A display device is mounted on and/or inside the eye. The eye mounted display contains multiple sub-displays, each of which projects light to different retinal positions within a portion of the retina corresponding to the sub-display. The projected light propagates through the pupil but does not fill the entire pupil. In this way, multiple sub-displays can project their light onto the relevant portion of the retina. Moving from the pupil to the cornea, the projection of the pupil onto the cornea will be referred to as the corneal aperture. The projected light propagates through less than the full corneal aperture. The sub-displays use spatial multiplexing at the corneal surface. Various electronic devices interface to the eye mounted display.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: November 5, 2019
    Assignee: Tectus Corporation
    Inventors: Michael F. Deering, Alan Huang
  • Patent number: 10342700
    Abstract: The present invention includes a device for effecting deformation of a sclera of an eye, including an expandable, mesh tube having holes dispersed through an entire surface thereof and with first and second tapered ends, and inserted unexpanded to deform the sclera when expanded. A central portion is intrascleral, with the first and second tapered ends external to the sclera on top of an intact scleral surface to deform during expansion, and simultaneously causes the sclera to be deformed so that the sclera moves towards the inside of the eye while simultaneously causing the sclera to move towards the outside of the eye. The mesh tube includes struts, connecting points of the struts are of different sizes, the first and second tapered ends and the connecting points within the tapered ends are thicker than the connecting points of the mesh tube, and the mesh tube includes fixation tabs.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: July 9, 2019
    Inventors: Ira H. Schachar, Ronald A. Schachar
  • Patent number: 10314478
    Abstract: A system for measuring microfluctuation of accommodation comprises a measuring module and a processing module. The measuring module includes at least one first sensing element attached to the area around an eye of a testee for measuring an EMG signal. The processing module is coupled with the measuring module for picking up a specific frequency range of the EMG signal as a measurement index of microfluctuation of accommodation, wherein the specific frequency range is between 0.1 Hz and 100 Hz. The system allows the testee to be tested in an open field of view and exempts the testee from experiencing fatigue in the muscle around the eyes. The system is compact and convenient to carry. A method for measuring microfluctuation of accommodation is also disclosed.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: June 11, 2019
    Assignee: National Chiao Tung University
    Inventors: Mang Ou-Yang, Jin-Chern Chiou, Ting-Wei Huang, Yi-Chun Tsai
  • Patent number: 10307293
    Abstract: Intraocular pressure can be reduced by insertion of an intraocular shunt in the eye such that it forms a drainage pathway between the anterior chamber and a region of lower pressure. A hollow shaft that holds an intraocular shunt can be advanced through the anterior chamber. The sclera can be penetrated with the hollow shaft. A beveled tip of the shaft can be oriented such that a beveled surface thereof faces toward the Tenon's capsule when the beveled tip passes out of the sclera. After the beveled tip passes out of the sclera, at least a portion of the shunt can be advanced from the hollow shaft.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: June 4, 2019
    Assignee: AqueSys, Inc.
    Inventors: Christopher Horvath, Laszlo O. Romoda, Richard A. Lewis
  • Patent number: 10292810
    Abstract: Embodiments of an intraocular lens are described. The intraocular lens includes a lens having a center and having positive or negative optical power and a pinhole mask formed on the lens. The pinhole mask includes one or more annular sections whose centers substantially coincide with the center of the lens, each of the one or more concentric annular sections having variable opacity, and a central section that is permanently transparent, the radius of the central section being adapted to allow the central section to act as a pinhole when the one or more concentric annular sections are made opaque.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: May 21, 2019
    Assignee: Verily Life Sciences LLC
    Inventors: Joshua N. Haddock, Dimitri T. Azar
  • Patent number: 10285804
    Abstract: A scleral prosthesis includes an elongated body having a first free end and a second free end opposite the first free end. A maximum width of the body at each end is wider than a maximum width of the body between the ends. The body includes multiple first portions that form the first free end of the body and a part of the body between the ends. The first portions are separated lengthwise along a substantial portion of a total length of the body. The first portions of the body are biased so that they maintain separation from one another without external interference but are configured to be pushed towards each other. The body is configured to receive and retain, between the first portions of the body, an insert that is configured to maintain the separation of the first portions.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: May 14, 2019
    Assignee: Refocus Group, Inc.
    Inventors: Harry R. A. Jacobson, Jack C. Griffis, III, Mark A. Cox, Douglas C. Williamson, Gene W. Zdenek, Peter J. Richardson, Michael K. Smolek, Barrie D. Soloway, Rex O. Bare, Andrew J. Scherer, Timothy J. Payne
  • Patent number: 10123869
    Abstract: The present invention relates generally to the restoration or improvement of the quality of human vision and, more particularly to a self-adapting system and method for achieving automatic sharp vision by the human eye of objects for instance at distances between 25 cm and more than 10 meters away. The invention can be situated in at least four technological domains: 1. ophthalmology, in particular the implantation of intraocular lenses. 2. Non-contact biometric signal recording and processing. 3. Electro-optic control of refractive lens power. 4. Wireless energy transfer.
    Type: Grant
    Filed: January 9, 2013
    Date of Patent: November 13, 2018
    Assignee: KATHOLIEKE UNIVERSITEIT LEUVEN
    Inventors: Johan Blanckaert, Christ Glorieux, Robert Puers
  • Patent number: 10095213
    Abstract: A system and method for designing scleral lenses includes a computer, a camera and a lathe connected by a network. The camera captures a set of sagittal images at each of a set of sagittal planes of an eye. A combined sagittal image is created from each set of sagittal images. A spline curve is defined for each combined sagittal image creating a set of spline curves. A set of back surface curves is created from the set of spline curves. A back lens surface is generated from the set of surface curves. A front lens surface is generated adjacent the back lens surface. A point cloud is generated from the back lens surface and the front lens surface. The point cloud is converted to a lens image. The lens is converted to a text file for use by the lathe to cut the scleral lens.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: October 9, 2018
    Inventor: Gregory Gemoules
  • Patent number: 10080682
    Abstract: Glaucoma can be treated by implanting an intraocular shunt into an eye. The eye has an anterior chamber and sclera. A shunt can be placed into the eye to establish fluid communication from the anterior chamber of the eye through the sclera, and a pharmaceutical or biological agent can be administered to the eye.
    Type: Grant
    Filed: May 18, 2016
    Date of Patent: September 25, 2018
    Assignee: AQUESYS, INC.
    Inventors: Christopher Horvath, Richard A. Lewis
  • Patent number: 10061143
    Abstract: Contact lenses incorporate multifocal power profiles that at least one of slow, retard or preventing myopia progression. The lens includes a first zone at a center of the ophthalmic lens and at least one peripheral zone surrounding the first zone. The at least one peripheral zone has a different width and dioptric power than the first zone. The first zone and at least one peripheral zone are stepped or discontinuous. The multifocal power profile has substantially equivalent foveal vision correction to a single vision lens and has a depth of focus and reduced retinal image quality sensitivity that slows, retards, or prevents myopia progression.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: August 28, 2018
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Noel A. Brennan, Khaled A. Chehab, Xu Cheng, Kurt John Moody, Xin Wei
  • Patent number: 9968442
    Abstract: An intraocular lens includes a lens capsule expanding device and an optical portion. A front supporting portion makes contact with an inner surface of an anterior capsule. A rear supporting portion makes contact with an inner surface of a posterior capsule while facing the front supporting portion. A connecting portion connects the front supporting portion and the rear supporting portion so as to have a biasing force to separate the front supporting portion and the rear supporting portion. Due to the biasing force, the front supporting portion presses the inner surface of the anterior capsule and the rear supporting portion presses the inner surface of the posterior capsule. The optical portion changes the curvature of a central portion according to movement of the connecting portion that moves the front supporting portion and the rear supporting portion closer to or away from each other with movement of the lens capsule.
    Type: Grant
    Filed: December 10, 2014
    Date of Patent: May 15, 2018
    Assignee: MIRAI EYE INC.
    Inventor: Junsuke Akura
  • Patent number: 9895260
    Abstract: The present invention includes a device and method for treatment of retinal detachment, ocular hypertension and glaucoma, and increasing an amplitude of accommodation. The device includes a tapered, mesh tube that within a sclera, expands to deform the sclera, and when placed within the posterior sclera for the treatment of a retinal tear, the device expands deforming the sclera so that the retinal pigment epithelium comes in contact with the retinal tear to seal the tear. For the treatment of ocular hypertension, glaucoma and to increase the amplitude of accommodation, the device is placed within the anterior sclera over the posterior plicata of the ciliary body, which upon expansion causes the underlying ciliary body to deform, resulting in traction on the trabecular meshwork and deformation of the ciliary body, which causes lowering of intraocular pressure, and increases the amplitude of accommodation in patients with ocular hypertension or decreased accommodation.
    Type: Grant
    Filed: October 20, 2016
    Date of Patent: February 20, 2018
    Inventors: Ira H. Schachar, Ronald A. Schachar
  • Patent number: 9883969
    Abstract: Glaucoma can be treated by implanting an intraocular shunt into an eye. The eye has an anterior chamber and sclera. A shunt can be placed into the eye to establish fluid communication from the anterior chamber of the eye through the sclera.
    Type: Grant
    Filed: January 25, 2016
    Date of Patent: February 6, 2018
    Assignee: AQUESYS, INC.
    Inventors: Christopher Horvath, Laszlo O. Romoda, Cory Anderson
  • Patent number: 9855232
    Abstract: The invention provides new crystalline forms of 7-[3,5-Dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-hept-5-enoic acid. This compound is commonly referred to as “bimatoprost acid.” The novel crystalline forms are designated forms I, II, and III. The invention crystalline forms are useful for solid ocular implant formulations, utilized in the treatment of various ocular conditions, such as, for example, ocular hypertension. In addition, invention crystalline forms are useful for solid or semisolid dosage formulations used to treat ocular hypertension.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: January 2, 2018
    Assignee: ALLERGAN, INC.
    Inventors: Ke Wu, Shaoxin Feng, Thomas K. Karami, Scott W. Smith
  • Patent number: 9844462
    Abstract: A surgical technique and device wherein an indwelling tube is placed in the eye of a patient having glaucoma. The tube diverts aqueous humor from the anterior chamber to the suprachoroidal space from which it is removed by blood flowing in the choroidal and uveal tissues. This decreases the intraocular pressure.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: December 19, 2017
    Assignee: Novartis AG
    Inventor: Michael Yablonski
  • Patent number: 9789312
    Abstract: A retinal prosthesis system according to an embodiment includes a converter, a retinal prosthesis, and a transmitter. The converter is placed in an eye, and transmits part of light incident on the eye therethrough while converting the energy of the other part of the light into electrical energy. The retinal prosthesis is placed in the eye and includes a photoelectric conversion element array configured to operate with the electrical energy received from the converter to detect the light having transmitted through the converter to generate an electrical signal. The transmitter is used to send the electrical signal generated by the retinal prosthesis to the visual cortex of the brain.
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: October 17, 2017
    Assignee: Kabushiki Kaisha Topcon
    Inventors: Yasufumi Fukuma, Hisashi Tsukada
  • Patent number: 9782293
    Abstract: The invention relates to an implant for reducing ocular hypertension. Said implant can be used in particular to prevent and treat glaucomas that are emerging or occur. In particular, the implant is an implant (10) for the Schlemm's canal, which comprises a bridge (20), which has a first end point (22) and a second end point (24) and a first support region (26), a second support region (28), and a connecting piece (30), the bridge (20) extending along a first line (L1) from the first end point (22) to the second end point (24) across the first support region (26), the connecting piece (30), and the second support region (28) and the connecting piece (30) having a first cross-sectional area on average along the first line (L1) and the first support region (26) having a second cross-sectional area on average along the first line (L1) after the implantation, characterized in that the second cross-sectional area is at least 50% larger than the first cross-sectional area.
    Type: Grant
    Filed: September 30, 2013
    Date of Patent: October 10, 2017
    Assignee: Doci Innovations GmbH
    Inventor: Violeta Doci
  • Patent number: 9763772
    Abstract: A reading enhancement device for preventing and/or treating presbyopia of the eye. The enhancement device is sutured to an outer wall of the sclera for buckling and compressing a portion of the sclera and the ciliary body inwardly and perpendicular to the plane of the sclera and exerting a posterior compression force toward the vitreous humor in the rear of the eye. The enhancement device includes a compression body with a front of the body having semi-circular convex surface. The convex surface is used for engaging, buckling and compressing both a portion of the sclera and the ciliary body of the eye. The compression body also includes an enlarged, rounded first and second end portions and an elongated center portion with the convex surface formed thereon. Also, the compression body includes a rear having an outwardly extending rib portion with a pair of grooves at opposite ends of the rib portion.
    Type: Grant
    Filed: June 18, 2015
    Date of Patent: September 19, 2017
    Inventor: Richard Damiano
  • Patent number: 9743932
    Abstract: Implantable occlusion devices that include one or more flanges extending from a tubular body are disclosed. The flange or flanges may assist in retention of the device within a vessel, cavity, appendage, etc. At least one flange on the occlusion device may include a concave surface proximate one end of a body. Because of the shape of the flange, e.g., its concavity, the occlusion device may resist dislocation due to e.g., the forces generated within the left atrial appendage during atrial fibrillation.
    Type: Grant
    Filed: June 27, 2006
    Date of Patent: August 29, 2017
    Assignee: ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC.
    Inventors: Kurt Amplatz, Gary A. Thill, Pat Russo, Xiaoping Gu, Jana Santer
  • Patent number: 9730785
    Abstract: A scleral prosthesis includes an elongated body configured to be implanted into scleral tissue of an eye. The body includes (i) opposing first and second free ends and (ii) multiple first portions that form the first end of the body and part of a remainder of the body between the ends. The first portions are separated along at least about half of a total length of the body by empty space such that the first portions meet at a point between the ends and are not connected to each other between that point and the first end. The ends are wider than the remainder. The scleral prosthesis also includes an insert configured to be placed between the first portions and to substantially fill the empty space. The body includes a convex upper surface extending lengthwise between the ends. The insert includes a convex upper surface extending lengthwise along the insert.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: August 15, 2017
    Assignee: Refocus Group, Inc.
    Inventors: Harry R. A. Jacobson, Jack C. Griffis, III, Mark A. Cox, Douglas C. Williamson, Gene W. Zdenek, Peter J. Richardson, Michael K. Smolek, Barrie D. Soloway, Rex O. Bare, Andrew J. Scherer, Timothy J. Payne
  • Patent number: 9717588
    Abstract: A scleral prosthesis includes an elongated body configured to be implanted into scleral tissue of an eye. The elongated body includes (i) opposing first and second free ends and (ii) multiple first portions that form the first end of the body and part of a remainder of the body between the first and second ends. The first and second ends are wider than the remainder of the body. The first portions are separated by empty space such that the first portions meet at a point between the first and second ends and are not connected to each other between that point and the first end. The first end projects beyond one or more sides of the remainder of the body and angles back towards the second end. The second end projects beyond the one or more sides of the remainder of the body and angles back towards the first end.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: August 1, 2017
    Assignee: REFOCUS GROUP, INC.
    Inventors: Harry R. A. Jacobson, Jack C. Griffis, III, Mark A. Cox, Douglas C. Williamson, Gene W. Zdenek, Peter J. Richardson, Michael K. Smolek, Barrie D. Soloway, Rex O. Bare, Andrew J. Scherer, Timothy J. Payne
  • Patent number: 9700406
    Abstract: A scleral prosthesis includes an elongated body and an insert. The body includes (i) opposing first and second free ends and (ii) multiple first portions that form the first end and part of a remainder of the body between the ends. The first portions are separated along at least about half of a total length of the body by empty space such that the first portions meet at a point between the ends and are not connected to each other between that point and the first end. The ends are wider than the remainder. The insert is configured to be placed between the first portions and to substantially fill the empty space. The first portions are biased so that they maintain separation from one another without external interference but are configured to be pushed towards each other in order to reduce a width of the first end. The insert, when placed between the first portions, keeps the first portions separated and prevents the first portions from being pushed together and reducing the width of the first end.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: July 11, 2017
    Assignee: Refocus Group, Inc.
    Inventors: Harry R. A. Jacobson, Jack C. Griffis, III, Mark A. Cox, Douglas C. Williamson, Gene W. Zdenek, Peter J. Richardson, Michael K. Smolek, Barrie D. Soloway, Rex O. Bare, Andrew J. Scherer, Timothy J. Payne
  • Patent number: 9687339
    Abstract: A scleral prosthesis includes an elongated body configured to be implanted into scleral tissue of an eye. The body includes (i) opposing first and second free ends and (ii) a pair of first portions that form the first end and part of a remainder of the body between the ends. The first portions are separated along at least about half of a total length of the body by empty space such that the first portions meet at a point between the ends and are not connected to each other between that point and the first end. The ends are wider than the remainder. The scleral prosthesis also includes an insert configured to be placed between the first portions and to substantially fill the empty space. The insert, prior to insertion, includes one or more slots. The first portions include one or more ridges configured to engage with the one or more slots of the insert.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: June 27, 2017
    Assignee: Refocus Group, Inc.
    Inventors: Harry R. A. Jacobson, Jack C. Griffis, III, Mark A. Cox, Douglas C. Williamson, Gene W. Zdenek, Peter J. Richardson, Michael K. Smolek, Barrie D. Soloway, Rex O. Bare, Andrew J. Scherer, Timothy J. Payne
  • Patent number: 9681983
    Abstract: An IOP control system for treatment of an ocular condition includes a drainage device sized for implantation into the eye of the patient, the drainage device including a fluid flow pathway to allow the flow of fluid from an inlet port to an outlet port. The drainage device also includes a flow system disposed within the drainage device and including a displaceable portion forming a part of the fluid flow pathway, the displaceable portion being displaceable via a magnetic field. An actuation system may be physically separate from the drainage device and may be configured to cooperate with the displaceable portion to displace the displaceable portion via the magnetic field to set free buildup or debris in the flow pathway.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: June 20, 2017
    Assignee: Novartis AG
    Inventor: Casey Lind
  • Patent number: 9662199
    Abstract: Systems and methods involving an intraocular implant with input and/or output electronics are described. In some embodiments, the system includes an intraocular lens having at least one optic operably coupled to a haptic, one or more input electronics on the haptic and/or the optic; and one or more output electronics on the haptic and/or the optic for receiving and/or transmitting data.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: May 30, 2017
    Assignee: STRATHSPEY CROWN HOLDINGS, LLC
    Inventor: Robert Edward Grant
  • Patent number: 9636255
    Abstract: Devices and methods for treating intraocular pressure are disclosed. The devices include drug delivery implants for treating ocular tissue. Optionally, the devices also include shunts for draining aqueous humor from the anterior chamber to the uveoscleral outflow pathway, including the supraciliary space and the suprachoroidal space. The drug delivery implants can be implanted in ab interno or ab externo procedures.
    Type: Grant
    Filed: February 12, 2010
    Date of Patent: May 2, 2017
    Assignee: DOSE MEDICAL CORPORATION
    Inventors: David Haffner, Kenneth Curry
  • Patent number: 9615917
    Abstract: This invention discloses methods and apparatus for providing an ophthalmic lens with a stacked integrated component device for function. In some embodiments, the stacked integrated component device may contain an energy source capable of powering an electrical component incorporated into the lens.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: April 11, 2017
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Frederick A. Flitsch, Daniel B. Otts, Randall B. Pugh
  • Patent number: 9534088
    Abstract: A polymeric material with a variable modulus of elasticity is described herein. The polymeric material described herein is useful for forming implantable medical devices (e.g. ophthalmic lenses, breast implants, and body augmentation devices). In addition, medical devices formed from the polymer material can be used to controllably release a therapeutic agent. Also, the polymeric material may be used to prepare topical compositions or other applications or devices where control of a mechanical property such as material modulus is important.
    Type: Grant
    Filed: March 6, 2013
    Date of Patent: January 3, 2017
    Assignee: Abbott Medical Optics Inc.
    Inventors: Can B Hu, Thuy Mai, Derek D Pham
  • Patent number: 9522059
    Abstract: A prosthetic capsular device configured to be inserted in an eye includes a housing structure and a ring structure. The housing structure includes a first side, a second side opposite the first side, a third side, a fourth side opposite the third side, a posterior side including a refractive surface, an anterior side opposite the posterior side, and a longitudinal axis. The first side, the second side, the third side, the fourth side, the posterior side, and the anterior side at least partially define a cavity configured to contain an intraocular device (e.g., an IOL). The anterior side includes an opening. The ring structure includes a ring structure portion extending radially outward from proximate one of an end of the first side and an end of the second side.
    Type: Grant
    Filed: May 17, 2016
    Date of Patent: December 20, 2016
    Assignee: Omega Ophthalmics LLC
    Inventors: Gary N. Wortz, Rick William Ifland
  • Patent number: 9504559
    Abstract: A scleral prosthesis includes an elongated body configured to be implanted into scleral tissue of an eye. The elongated body includes opposing first and second ends. Multiple portions form the first end of the body and part of a remainder of the body between the first and second ends. The first and second ends are wider than the remainder of the body. The multiple portions of the body are separated by empty space such that the multiple portions meet at a point between the first and second ends of the body and are not connected to each other between that point and the first end of the body. The second end of the body is integral with the remainder of the body and not divided into multiple separated portions.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: November 29, 2016
    Assignee: Refocus Group, Inc.
    Inventors: Harry R. A. Jacobson, Jack C. Griffis, III, Mark A. Cox, Douglas C. Williamson, Gene W. Zdenek, Peter J. Richardson, Michael K. Smolek, Barrie D. Soloway, Rex O. Bare, Andrew J. Scherer, Timothy J. Payne
  • Patent number: 9498324
    Abstract: A scleral prosthesis includes an elongated body configured to be implanted into scleral tissue of an eye. The elongated body includes (i) opposing first and second ends and (ii) multiple first portions that form the first end of the body and part of a remainder of the body between the first and second ends. The first portions of the body are separated by empty space, and the first and second ends are wider than the remainder of the body. The scleral prosthesis also includes an insert configured to be placed and retained between the first portions of the body. At least part of the insert, prior to insertion between the first portions of the body, has a shape complementary to a shape of the empty space.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: November 22, 2016
    Assignee: Refocus Group, Inc.
    Inventors: Harry R. A. Jacobson, Jack C. Griffis, III, Mark A. Cox, Douglas C. Williamson, Gene W. Zdenek, Peter J. Richardson, Michael K. Smolek, Barrie D. Soloway, Rex O. Bare, Andrew J. Scherer, Timothy J. Payne
  • Patent number: 9474594
    Abstract: The present invention relates generally to a device and method for the treatment of retinal detachment, ocular hypertension and glaucoma, and increasing the amplitude of accommodation. In an illustrative embodiment, the device includes a tapered, mesh tube. Once the device is within the sclera, the mesh expands to deform the sclera. When the device is placed within the posterior sclera for the treatment of a retinal tear, the device expands deforming the sclera so that the retinal pigment epithelium comes in contact with the retinal tear to seal the tear.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: October 25, 2016
    Inventors: Ira H. Schachar, Ronald A. Schachar
  • Patent number: 9452044
    Abstract: A scleral prosthesis includes an elongated body configured to be implanted into scleral tissue of an eye. The elongated body includes (i) opposing first and second ends and (ii) multiple first portions that form the first end of the body and part of a remainder of the body between the ends. The first and second ends are wider than the remainder of the body. The first portions of the body are separated lengthwise along the body by empty space such that the first portions meet at a point between the first and second ends of the body and are not connected to each other between that point and the first end. The scleral prosthesis also includes an insert configured to be placed and retained between the first portions of the body. The insert has a length that is at least about half of a length of the elongated body.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: September 27, 2016
    Assignee: Refocus Group, Inc.
    Inventors: Harry R. A. Jacobson, Jack C. Griffis, III, Mark A. Cox, Douglas C. Williamson, Gene W. Zdenek, Peter J. Richardson, Michael K. Smolek, Barrie D. Soloway, Rex O. Bare, Andrew J. Scherer, Timothy J. Payne
  • Patent number: 9254189
    Abstract: A vision prosthesis includes an optical element having a characteristic function associated with refraction therethrough. The characteristic function is selected to reduce aberration in an eye when the optical element is implanted at a location therein.
    Type: Grant
    Filed: March 6, 2012
    Date of Patent: February 9, 2016
    Assignee: Massachusetts Eye and Ear Infirmary
    Inventor: Dimitri T. Azar
  • Patent number: 9204930
    Abstract: Lens epithelial cells are destroyed and further growth is inhibited coincidental with eye surgery such as cataract surgery by heating the cells to a temperature above normal to thereby destroy the cells and inhibit future growth. The cells are heated by placement of a thermally conductive ring within the lens capsule and heating the ring thereby raising the temperature of lens epithelial cells adjacent to the ring.
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: December 8, 2015
    Inventor: David C. Brown
  • Patent number: 9180048
    Abstract: An eye shape modification (ESM) system such as a scleral buckle featuring a band having a first end, a second end opposite the first end, and a first side; and a fixation zone disposed on the first side of the band. The fixation zone is adapted to accept sutures and can be sutured to a scleral surface. The ESM system may also feature a closure system for closing the two ends of the band together. The ESM system may also feature a calibrated shortening mechanism allowing a calibrated reduction in circumference and diameter.
    Type: Grant
    Filed: September 9, 2013
    Date of Patent: November 10, 2015
    Inventor: Robert Park
  • Patent number: 9044316
    Abstract: Many modem implantable ophthalmic devices include electronic components, such as electro-active cells, that can leak harmful substances into the eye and/or surrounding tissue. In the implantable ophthalmic devices disclosed herein, electronic components are hermetically sealed to facilitate mechanically connecting components of an implantable ophthalmic device. Furthermore, the device includes at least one battery with a surface comprising electrical contact portions, a housing for the at least one battery, a first wafer bonded to the housing such that the housing and the first wafer form a hermetically sealed surface around the battery, and an electronic circuit electrically connected to the electrical contact portions of the battery.
    Type: Grant
    Filed: September 6, 2011
    Date of Patent: June 2, 2015
    Assignee: ELENZA, INC.
    Inventors: Jean-Noel Fehr, Alain Saurer, Andreas Schlappi
  • Publication number: 20150142106
    Abstract: The present invention relates to a prosthetic capsular bag and method for inserting the same. The prosthetic capsular bag helps to maintain the volume of the natural capsular bag, thereby stabilizing the effective lens position of an IOL so that refractive outcomes may be improved with cataract surgery. The prosthetic capsular bag further provides an integrated refractive surface, providing a means for experimentally determining an effective lens position prior to inserting an IOL.
    Type: Application
    Filed: January 29, 2015
    Publication date: May 21, 2015
    Inventor: Gary N. Wortz
  • Patent number: RE45625
    Abstract: A reading enhancement device for preventing and/or treating presbyopia of the eye. The enhancement device is sutured to an outer wall of the sclera for buckling and compressing a portion of the sclera and the ciliary body inwardly and perpendicular to the plane of the sclera and exerting a posterior compression force toward the vitreous humor in the rear of the eye. The enhancement device includes a compression body with a front of the body having semi-circular convex surface. The compression body made of a non-metallic, synthetic polymer. The convex surface is used for engaging, buckling and compressing both a portion of the sclera and the ciliary body of the eye. The compression body also includes an enlarged, rounded first and second end portions and an elongated center portion with the convex surface formed thereon. Also, the compression body includes a rear having an outwardly extending rib portion with a pair of grooves at opposite ends of the rib portion.
    Type: Grant
    Filed: April 30, 2014
    Date of Patent: July 28, 2015
    Inventor: Richard Damiano
  • Patent number: RE47006
    Abstract: A method for treating progression of a refractive disorder in a human eye. The method includes the steps of producing a first image on a retina of the human eye and producing a second image to generate a defocus.
    Type: Grant
    Filed: August 11, 2014
    Date of Patent: August 28, 2018
    Assignee: The Hong Kong Polytechnic University
    Inventors: Chi Ho To, Siu Yin Lam, Yan Yin Tse